Acquiring Company
Crown Bioscience
Acquired Company
Indivumed
Description
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH. A Share Purchase Agreement (SPA) between both parties was executed on December 29, 2022, and subject to customary closing adjustments the transaction is expected to close in April 2023.
Quick answer
Crown Bioscience is acquiring Indivumed, announced January 25, 2023. Crown Bioscience is based in San Diego, California, United States.
- How much did Crown Bioscience pay for Indivumed?
- The deal value was not disclosed.
- What does Crown Bioscience do?
- Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to advancing human health by partnering with biotech and pharmaceutical companies that drive drug discovery and..
- Where are Crown Bioscience and Indivumed based?
- Crown Bioscience is based in San Diego, California, United States.
- Who are the decision-makers at Crown Bioscience?
- Fundz holds 1 contact at Crown Bioscience. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Analytics and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Bayer Acquires Blackford Analysis Ltd. Bolstering The Company’S Position In Digital Medical Imaging (January 18, 2023)
- Clarapath Acquires Crosscope And Combines Tissue Processing Robotics With Ai Powered Digital Pathology For Building The Lab Of The Future (February 27, 2023)
- Rhythm Pharmaceuticals Announces Acquisition Of Xinvento B.V. And Portfolio Of Investigational Therapeutics (February 27, 2023)
- Kymanox Acquires Eu Based Anteris Medical And Anteris Helvetia (February 2, 2023)
- Quartzbio, A Part Of Precision For Medicine, Acquires Solvebio And Expands Software-As-A-Service (Saas) Data Management Solutions For Clinical Research & Development (R&D) (January 24, 2023)
- Cultivate(Md) Capital Funds Announces Portfolio Company Embody'S Acquisition By Zimmer Biomet Holdings, Inc. (January 10, 2023)
Who to call at Crown Bioscience, and when
When Crown Bioscience changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Crown Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Crown Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Crown Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Crown Bioscience makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Indivumed?
Indivumed was acquired by Crown Bioscience, based in San Diego. The deal was reported on January 25, 2023. Crown Bioscience is privately held and operates in Biotechnology.
When did Crown Bioscience acquire Indivumed?
Crown Bioscience's acquisition of Indivumed was reported on January 25, 2023. Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Indivumed do?
It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.